Nang Kuang Pharmaceutical Co., Ltd. (TPE:1752)
Taiwan · Delayed Price · Currency is TWD 31.50
-0.25 (-0.79%)
Sep 8, 2026, 1:30 PM CST
Nang Kuang Pharmaceutical Market Cap
Nang Kuang Pharmaceutical has a market cap or net worth of 3.18 billion as of September 8, 2026. Its market cap has decreased by -18.08% in one year.
Market Cap
3.18B
Enterprise Value
3.51B
Revenue
2.11B
Ranking
n/a
PE Ratio
15.51
Stock Price
31.50
ChartMarket Cap Chart
Since May 12, 2006, Nang Kuang Pharmaceutical's market cap has increased from 1.08B to 3.18B, an increase of 193.87%. That is a compound annual growth rate of 5.44%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 8, 2026 | 3.18B | -15.55% |
| Dec 31, 2025 | 3.77B | -9.36% |
| Dec 31, 2024 | 4.16B | -22.80% |
| Dec 29, 2023 | 5.38B | -16.59% |
| Dec 30, 2022 | 6.45B | 65.97% |
| Dec 30, 2021 | 3.89B | -2.78% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Medeon Biodesign | 7.10B |
| Pacific Hospital Supply | 5.66B |
| Formosa Optical Technology | 5.50B |
| St.Shine Optical | 4.97B |
| Bionime | 4.53B |
| ICARES Medicus | 3.67B |
| SciVision Biotech | 3.52B |
| Maxigen Biotech | 3.43B |